A New Generation Chronic Myeloid Leukemia Treatment Strategy Through The Utilization Of CRISPR/Cas9 Mediated Gene Therapy

Basit Öğe Kaydı
dc.contributor.authorSomuncu, Makbule
dc.contributor.authorYildirim, Mahmut Selman
dc.contributor.authorAydin, Cihan
dc.contributor.authorZamani, Ayse Gul
dc.contributor.authorAlbayrak, Esra
dc.contributor.authorDuran, Tugce
dc.contributor.authorKavakli, Ibrahim Halil
dc.date.accessioned2025-11-16T19:35:06Z
dc.date.issued2024
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description57th Conference of the European-Society-of-Human-Genetics (ESHG) -- JUN 01-04, 2024 -- Berlin, GERMANY
dc.description.abstract[Abstract Not Available]
dc.description.sponsorship[181418003]
dc.description.sponsorshipThis project was financed by the budget given for doctoral theses by the scientific research organization of Necmettin Erbakan University, Medicine Faculty, Project number; 181418003).
dc.description.sponsorshipEuropean Soc Human Genetics
dc.identifier.endpage1204
dc.identifier.issn1018-4813
dc.identifier.issn1476-5438
dc.identifier.startpage1204
dc.identifier.urihttps://hdl.handle.net/20.500.14730/15543
dc.identifier.volume32
dc.identifier.wosWOS:001421430501222
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherSpringernature
dc.relation.ispartofEuropean Journal of Human Genetics
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.subjectBCR:ABL1(p210)
dc.subjectCML
dc.subjectCRISPR/Cas9
dc.titleA New Generation Chronic Myeloid Leukemia Treatment Strategy Through The Utilization Of CRISPR/Cas9 Mediated Gene Therapy
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu